Home › Funds › M28 Capital Management LP › PRQR

M28 Capital Management LP position in PRQR

PROQR THRAPEUTICS N V · Health Care

M28 Capital Management LP reported holding 599,793 shares of PRQR (PROQR THRAPEUTICS N V) in its Q3 2026 13F filing — a position valued at US$996K, representing 2.76% of its reported portfolio and ranking #7 among its reported holdings. M28 Capital Management LP has disclosed PRQR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)599.79K sh
Reported value held$995.66K
Portfolio Weight2.76%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How M28 Capital Management LP's PRQR position evolved

M28 Capital Management LP first disclosed a stake in PRQR in Q3 2023 at 1,910,600 shares (US$2.5M). The position peaked in Q4 2023 at 1,910,600 shares, worth US$3.8M. Across 13 filings, M28 Capital Management LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 599,793 shares valued at US$996K. Notable position changes include a 47% trim in Q1 2024 (shares fell 28% over the following quarter), a 41% trim in Q1 2026 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.91M $2.48M New
Q4 2023 1.91M $3.78M Hold
Q1 2024 1.02M $2.33M Reduce
Q2 2024 1.02M $1.69M Hold
Q3 2024 1.02M $1.86M Hold
Q4 2024 1.02M $2.70M Hold
Q1 2025 1.02M $1.36M Hold
Q2 2025 1.02M $2.08M Hold
Q3 2025 1.02M $2.17M Hold
Q4 2025 1.02M $2.06M Hold
Q1 2026 599.79K $971.66K Reduce
Q2 2026 599.79K $1.12M Hold
Q3 2026 599.79K $995.66K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRQR and 13F data

PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 38 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$9.1M), Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRQR

All PRQR fund holders →

FAQ

How long has M28 Capital Management LP held PRQR?

M28 Capital Management LP has disclosed PRQR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is M28 Capital Management LP's current position in PRQR?

As of Q3 2026, M28 Capital Management LP holds 599.79K shares of PRQR (PROQR THRAPEUTICS N V), valued at $995.66K, representing 2.76% of its reported portfolio and ranking #7.

Has M28 Capital Management LP been buying or selling PRQR?

In the latest 13F filing (Q3 2026), M28 Capital Management LP held unchanged its position in PRQR. The position peaked in Q4 2023 at 1.91M shares.

Which other funds hold PRQR?

Other major institutional holders of PRQR include Privium Fund Management B.V., Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.